Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	2,124	1,014	1,268	450	474	390
Market Cap Growth	188.51%	-20.02%	181.72%	-4.95%	21.42%	37.70%
Enterprise Value	2,070	942.33	1,166	484.73	461.44	299.21
Last Close Price	21.64	10.51	14.12	7.16	8.08	6.68
PE Ratio	-	-	-	-	-	51.38
Forward PE	33.17	200.19	-	-	-	-
PS Ratio	8.42	6.00	45.36	-	-	17.47
PB Ratio	21.42	13.74	14.46	-21.29	6.05	2.40
P/TBV Ratio	21.67	13.54	12.90	-20.35	6.05	2.26
EV/Sales Ratio	8.33	5.57	41.69	-	-	13.40
EV/EBITDA Ratio	766.89	-	-	-	-	39.87
EV/EBIT Ratio	-	-	-	-	-	51.46
Debt / Equity Ratio	0.03	0.02	0.03	-6.20	1.85	0.80
Debt / EBITDA Ratio	0.31	-	-	-	-	17.39
Debt / FCF Ratio	0.07	-	-	-	-	-
Asset Turnover	1.37	1.03	0.19	0	0	0.10
Inventory Turnover	0.57	1.00	0.16	-	-	3.22
Quick Ratio	2.14	2.21	3.18	1.77	7.60	14.87
Current Ratio	2.76	2.75	3.64	1.81	9.17	17.44
Return on Equity (ROE)	-0.32%	-60.44%	-481.35%	-481.49%	-64.30%	10.56%
Return on Assets (ROA)	2.49%	-25.65%	-92.39%	-63.98%	-25.41%	-3.47%
Return on Invested Capital (ROIC)	9.66%	-127.05%	-610.90%	-252.56%	-91.04%	-11.31%
Return on Capital Employed (ROCE)	3.58%	-34.86%	-134.60%	-65.00%	-32.73%	2.82%
Earnings Yield	-	-	-	-	-	1.95%
Buyback Yield / Dilution	-3.42%	-18.67%	-33.41%	-2.66%	-6.54%	-46.89%
Total Shareholder Return	-3.42%	-18.67%	-33.41%	-2.66%	-6.54%	-46.89%

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q